Ovid Therapeutics stock gains on positive epilepsy trial data
Ovid Therapeutics Inc. (NASDAQ: OVID) stock climbed to an 8-month high of $3.05 on Tuesday after positive initial data from…
Is Lululemon’s bull run coming to an end?
Lululemon Athletica (NASDAQ: LULU) is one apparel brand that has been cruising despite the onslaught of online shopping giants. Since…
Exxon Mobil can be an ideal option for long-term investment
Shares of oil and natural gas company Exxon Mobil (NYSE: XOM) gained abruptly earlier this month after oil prices surged…